Catalent Completes Shanghai Clinical Supply Facility

Catalent Pharma Solutions has completed construction and validation of its clinical supply facility in Shanghai, China, which will provide clinical supply solutions from clinical supply management, comparator sourcing and primary packaging, to storage and distribution. The facility is also validated to support biologics requiring refrigerated and frozen supply chain management.
 
The new 31,000-sq.-ft. facility has been constructed to the company’s ‘center of excellence’ guidelines and will operate under Catalent’s global Quality Management System. The Catalent (Shanghai) Clinical Trial Supplies Co., Ltd. facility is the company’s eighth global clinical supply network site and is located in Shanghai’s Waigaoqiao Free Trade Zone.
 
“China is a fast growing market for the pharmaceutical industry and a market that Catalent will continue to invest in,” said Scott Houlton, president of Development and Clinical Services at Catalent. “Having started work on our China clinical supply strategy two years ago, I’m excited to see this strategy implemented and the new site open for business. It is a great addition to Catalent’s global clinical supply network and will help to better serve our customers increasing need for clinical trials in Asia.”